Aldosterone-targeted therapies: early implementation in resistant hypertension and chronic kidney disease. Kobayashi M, Pitt B, Ferreira JP, Rossignol P, et al. Eur Heart J 2025 Apr 11:ehaf225. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kobayashi M, Pitt B, Ferreira JP, Rossignol P, et al. Aldosterone-targeted therapies: early implementation in resistant hypertension and chronic kidney disease. Eur Heart J 2025 Apr 11:ehaf225. doi: 10.1093.
PMID: 40214750